Search research articles
Contact Us
Filters
Showing results (611-620 of 632) with videos related to
Page
of 64
Sort By:
Journal of Lipid Research
|
June 7, 2017
GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy
Santhosh Satapati, Ying Qian, Margaret S Wu, et al.
Cell Reports
|
December 15, 2021
IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virus
Yang Yu, Na Xu, Qi Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
Yanhong Deng, Pan Chi, Ping Lan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2024
Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 Years
Jianwei Zhang, Pan Chi, Lishuo Shi, et al.
The Oncologist
|
January 5, 2021
Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial
Huabin Hu, Kun Wang, Meijin Huang, et al.
Mobile DNA
|
June 28, 2018
Unexpected invasion of miniature inverted-repeat transposable elements in viral genomes
Hua-Hao Zhang, Qiu-Zhong Zhou, Ping-Lan Wang, et al.
Annals of Surgery
|
July 11, 2022
Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial
Huashan Liu, Ziwei Zeng, Hong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2019
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
Yanhong Deng, Pan Chi, Ping Lan, et al.
Cell Death and Differentiation
|
April 9, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins
Jia-Nan Gong, Tirta M Djajawi, Donia M Moujalled, et al.
JAMA
|
January 23, 2025
Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical Trial
Ziwei Zeng, Shuangling Luo, Hong Zhang, et al.
Page
of 64
Search research articles
Search
Showing results (611-620 of 632) with videos related to
Sort By:
Page
of 64
Journal of Lipid Research
|
June 7, 2017
GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy
Santhosh Satapati, Ying Qian, Margaret S Wu, et al.
Cell Reports
|
December 15, 2021
IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virus
Yang Yu, Na Xu, Qi Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
Yanhong Deng, Pan Chi, Ping Lan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2024
Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 Years
Jianwei Zhang, Pan Chi, Lishuo Shi, et al.
The Oncologist
|
January 5, 2021
Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial
Huabin Hu, Kun Wang, Meijin Huang, et al.
Mobile DNA
|
June 28, 2018
Unexpected invasion of miniature inverted-repeat transposable elements in viral genomes
Hua-Hao Zhang, Qiu-Zhong Zhou, Ping-Lan Wang, et al.
Annals of Surgery
|
July 11, 2022
Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial
Huashan Liu, Ziwei Zeng, Hong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2019
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
Yanhong Deng, Pan Chi, Ping Lan, et al.
Cell Death and Differentiation
|
April 9, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins
Jia-Nan Gong, Tirta M Djajawi, Donia M Moujalled, et al.
JAMA
|
January 23, 2025
Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical Trial
Ziwei Zeng, Shuangling Luo, Hong Zhang, et al.
Page
of 64